Evidence map›Paper›PMID 26826595›Full record

ArticleJournal of epidemiology and global health2016

Verification of measles elimination in Australia: Application of World Health Organization regional guidelines.

H F Gidding, N V Martin, V Stambos, T Tran, A Dey, G K Dowse, H A Kelly, D N Durrheim, S B Lambert

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of epidemiology and global health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

H F GiddingSchool of Public Health and Community Medicine, UNSW Medicine, Sydney, Australia; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital Network, Westmead, New South Wales, Australia. Electronic address: hgidding@unsw.edu.
N V MartinOffice of Health Protection, Department of Health, Canberra, Australia.
V StambosVictorian Infectious Diseases Reference Laboratory, Melbourne, Australia.
T TranVictorian Infectious Diseases Reference Laboratory, Melbourne, Australia.
A DeyNational Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital Network, Westmead, New South Wales, Australia; The University of Sydney, New South Wales, Australia.
G K DowseCommunicable Disease Control Directorate, Department of Health, Perth, Western Australia, Australia.
H A KellyVictorian Infectious Diseases Reference Laboratory, Melbourne, Australia; Australian National University, Canberra, Australia.
D N DurrheimSchool of Medicine and Public Health, University of Newcastle, New South Wales, Australia.
S B LambertQueensland Children's Medical Research Institute, Children's Hospital and Health Service, Queensland Health, Australia; UQ Child Health Research Centre, The University of Queensland, Australia; Communicable Diseases Branch, Prevention Division, Queensland Health, Australia.
Victorian Infectious Diseases Reference Laboratory · AUAustralian National University · AUDepartment of Health · AUGovernment of Western Australia Department of Health · AUNational Centre for Immunisation Research & Surveillance · AUQueensland Health · AUUniversity of Newcastle Australia · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) Western Pacific Region (WPR) Guidelines on verification of measles elimination were established in 2012. This article outlines Australia's approach to addressing the guideline's five lines of evidence, which led to formal verification of elimination by the WHO Regional Verification Commission (RVC) in March 2014.

methodsThe criteria were addressed using national measles notifications, data from selected laboratories, the national childhood immunization register, and three national serosurveys (1998/1999, 2002, 2007).

resultsAustralia met or exceeded all indicator targets with either national or sentinel data. Laboratory and epidemiological surveillance were of high quality, with 85% of cases documented as imported/import-related (target 80%); coverage with the first dose of measles vaccine was close to 94% in 2008-2012 and second dose coverage increased to 91% in 2012 (target >95%). There is ongoing commitment by the Australian Government to increase immunization coverage, and the absence of sustained transmission of any single measles genotype was demonstrated.

conclusionsThis is the first documentation of the successful application of the WPR RVC guidelines. The indicators afford some flexibility but appear to provide appropriate rigor to judge achievement of measles elimination. Our experience could assist other countries seeking to verify their elimination status.

Indexed as

World Health OrganizationAdolescentAdultAustraliaChildChild, PreschoolFemaleGuideline AdherenceHumansInfantMaleMeaslesMeasles VaccineMiddle AgedPopulation SurveillanceYoung AdultMeasles VaccineDisease eliminationMeaslesSurveillance

Identifiers

PMID26826595
PMCPMC7320480
OpenAlexW2281796171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.